Speaker:

During this presentation, Dr. Diana Morlote, assistant professor of pathology at the University of Alabama at Birmingham, discusses the recent implementation of a rapid, automated next-generation sequencing (NGS) assay in her research laboratory for genomic profiling of acute myeloid leukemia (AML) and other related hematological disorders. The data being presented were collected from several archive cases using the Oncomine Myeloid Assay GX and the Genexus System. Analytical performance is discussed for various key mutations detected using DNA inputs. Dr. Morlote describes how this solution addresses key challenges with molecular analysis of AML and other related malignancies. This research furthers our understanding of malignant hematological disorders and may lead to better care in the future.